PRODIGY: personalized prioritization of driver genes.

ABSTRACT:

Motivation

Evolution of cancer is driven by few somatic mutations that disrupt cellular processes, causing abnormal proliferation and tumor development, whereas most somatic mutations have no impact on progression. Distinguishing those mutated genes that drive tumorigenesis in a patient is a primary goal in cancer therapy: Knowledge of these genes and the pathways on which they operate can illuminate disease mechanisms and indicate potential therapies and drug targets. Current research focuses mainly on cohort-level driver gene identification but patient-specific driver gene identification remains a challenge.

Methods

We developed a new algorithm for patient-specific ranking of driver genes. The algorithm, called PRODIGY, analyzes the expression and mutation profiles of the

SUBMITTER: Dinstag G 

PROVIDER: S-EPMC7703777 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature